Do All Critically Ill Patients with COVID-19 Disease Benefit from Adding Tocilizumab to Glucocorticoids? A Retrospective Cohort Study
Cristina Mussini(University of Modena and Reggio Emilia), Giovanni Guaraldi(University of Modena and Reggio Emilia), Matteo Faltoni(University of Modena and Reggio Emilia), Enrico Clini(Azienda Ospedaliero-Universitaria di Modena), Vittorio Iadisernia(Azienda Ospedaliero-Universitaria di Modena), Elena Corradini(Harvard University), Martina Del Monte(University of Modena and Reggio Emilia), Elisa Romagnoli(Azienda Ospedaliero-Universitaria di Modena), Alessandro Cozzi‐Lepri(University College London), Antonello Pietrangelo(Policlinico di Modena), Erica Franceschini(University of Modena and Reggio Emilia), Marianna Meschiari(Azienda Ospedaliero-Universitaria di Modena), Andrea Dessilani(University of Modena and Reggio Emilia), Roberto Tonelli(University of Modena and Reggio Emilia), Vanni Borghi(University of Modena and Reggio Emilia), Stefano Busani(University of Modena and Reggio Emilia), Jovana V. Milić(École Polytechnique Fédérale de Lausanne), Massimo Girardis(University of Modena and Reggio Emilia), Jacopo Conti(University of Modena and Reggio Emilia), Sara Volpi(University of Modena and Reggio Emilia), Andrea Cossarizza(University of Modena and Reggio Emilia), Licia Gozzi(University of Modena and Reggio Emilia), Lucio Brugioni(Azienda Ospedaliero-Universitaria di Modena), Giacomo Franceschi(University of Modena and Reggio Emilia), Giulia Burastero(Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda)
Cited by 5
Related Papers
An Official American Thoracic Society/European Respiratory Society Statement: Key Concepts and Advances in Pulmonary Rehabilitation
|American Journal of Respiratory and Critical Care Medicine|2013|3.8k
Premature Age-Related Comorbidities Among HIV-Infected Persons Compared With the General Population
|Clinical Infectious Diseases|2011|1.3k
Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition)
|European Journal of Immunology|2019|1k
Tocilizumab in patients with severe COVID-19: a retrospective cohort study
|The Lancet Rheumatology|2020|998
Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with COVID-19 pneumonia
|Nature Communications|2020|846